LISLE, Ill., Nov. 12, 2025 /PRNewswire/ — Hubly Surgical today announced FDA 510(k) clearance expanding Hubly Auto-Stop Drill indications to include spinal
Contract awarded for products that bring improvement to healthcare industry LISLE, Ill., Sept. 18, 2025 /PRNewswire/ — Hubly Surgical, a leader in safe
We’re thrilled to share a major milestone—5,000 Hubly Auto-Stop Drills have been sold to save lives across the country! And
Fox 32 Chicago on Hubly Surgical “Doctors say it’s way better than what’s commonly used across the country—a hand-crank drill—because
Northwestern Medicine on Hubly Surgical Disclaimer: The efficacy and safety claims posited in this news segment represent user perspectives alone.
ABC 7 Chicago on Hubly Surgical Disclaimer: The efficacy and safety claims posited in this news segment represent user perspectives
The Hubly Surgical Bedside Cranial Access Kit + Drill, with first-of-its-kind SMART Auto-Stop for use in any setting, is successfully
LISLE, Ill., Aug. 18, 2023 /PRNewswire/ — Hubly Surgical announced today the results from the first peer-reviewed study comparing the safety and efficacy
LISLE, Ill., July 21, 2023 /PRNewswire/ — Hubly Surgical, a leader in neurosurgical innovation, has successfully closed its Series Seed funding round
Hubly Surgical is proud to announce that HUBLY CRANIAL ACCESS KIT + DRILL, the first and only single-use cranial drill with advanced
Hubly Surgical is the future of safer neurotechnology, with a commitment to improving outcomes for many patients undergoing intracranial access
Fox 32 Chicago on Hubly Surgical “Doctors say it’s way better than what’s commonly used across the country—a hand-crank drill—because
Northwestern Medicine on Hubly Surgical Disclaimer: The efficacy and safety claims posited in this news segment represent user perspectives alone.
ABC 7 Chicago on Hubly Surgical Disclaimer: The efficacy and safety claims posited in this news segment represent user perspectives
LISLE, Ill., Aug. 18, 2023 /PRNewswire/ — Hubly Surgical announced today the results from the first peer-reviewed study comparing the safety and efficacy
